siPLG (SeraGene Therapeutics Inc)

N/A

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NamesiPLG (SeraGene Therapeutics Inc)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionPlasminogen inhibitors
TargetsPlasminogen
Therapy Area/IndicationsHemorrhageHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSeraGene Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSeraGene Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHemorrhageHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A